Does anyone have any insights as to why it seems like AZ has mismanaged everything from the start?
The EU started negotiating later and signed a contract with fewer remedies than the UK (https://www.politico.eu/article/the-key-differences-between-...). It's not at all surprising that AZ is focusing their efforts on the UK.
Must have been some contract...
but this is still a guess at this point.
Did Moderna get more support from other companies/the government?
(I suppose my point is that I would have expected such teething problems from a young company like Moderna, but they seem to have done everything right.)